Literature DB >> 28103001

Adaptive Randomization of Neratinib in Early Breast Cancer.

Heikki Joensuu1.   

Abstract

Entities:  

Year:  2016        PMID： 28103001     DOI： 10.1056/NEJMc1609993

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  1 in total

Review 1.  Adaptive Designs for Clinical Trials: Application to Healthcare Epidemiology Research.

Authors:  W Charles Huskins; Vance G Fowler; Scott Evans
Journal:  Clin Infect Dis       Date:  2018-03-19       Impact factor: 9.079
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.